Spread of artemisinin resistance in malaria

New England Journal of Medicine

Volumn 371, Issue 20, 2014, Pages 1944-1945

  Hawkes, Michael ^a   Conroy, Andrea L ^b   Kain, Kevin C ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; PROTOZOAL PROTEIN;

AFRICA; ANTIMALARIAL DRUG RESISTANCE; DISEASE SEVERITY; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; LETTER; MALARIA FALCIPARUM; PARASITE CLEARANCE; SOUTHEAST ASIA; UGANDA; DRUG RESISTANCE; GENETICS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM;

ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 84910145027     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1410735     Document Type: Letter

References (5)

1. Ashley EA, Dhorda M, Fairhurst RM, et al. Spread of arte-misinin resistance in Plasmodium falciparum malaria. N Engl J Med 2014;371:411-23.
2. Amaratunga C, Sreng S, Suon S, et al. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Lancet Infect Dis 2012;12:851-8.
3. Lopera-Mesa TM, Doumbia S, Chiang S, et al. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity. J Infect Dis 2013;207:1655-63.
4. Hawkes M, Opoka RO, Namasopo S, et al. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials 2011;12:176.
5. Flegg JA, Guerin PJ, White NJ, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J 2011;10:339.